FDA Inspection 1195023 — Palatin Technologies, Inc.

Palatin Technologies, Inc. — FEI 3001642225

The FDA completed an inspection of Palatin Technologies, Inc. on Dec 16, 2022 in East Windsor, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 16, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Windsor, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.